Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

- Glioblastoma Multiforme
- Completed

Study Title: Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Teva Identifier: IXR-202-22-188

ClinicalTrials.gov Identifier: NCT00104091

Study Status: Completed

Trial Condition(s): Glioblastoma Multiforme

Interventions: Drug: TP-38

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: 12/01/2004 - 06/01/2007

Phase: Phase 2

Study Type

Interventional